SCHEMBL18323628

SCHEMBL18323628

Cc1nnc2cc(C(N)=O)cc(C3CC3)n12

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.37
KDM4E B2RXH2 1/20 0.36
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CCNA1 P78396 1/20 0.31
JAK2 O60674 2/20 0.31
JAK1 P23458 2/20 0.31
TYK2 P29597 2/20 0.31
JAK3 P52333 2/20 0.31
KMT2A Q03164 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18323580 0.87 KDM4E (0.37) BRD4KDM4ECHRNB2CHRNB4CHRNA3
SCHEMBL18323594 0.83 KDM4E (0.38) KDM4ECHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL18323678 0.82 CYP2C9 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4CYP2C9
SCHEMBL15907120 0.82 MEN1 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4CYP2C9
SCHEMBL18323618 0.79 KDM4E (0.55) BRD4KDM4ELMNAKMT2ATSHR
SCHEMBL18323643 0.77 KDM4E (0.56) BRD4KDM4ELMNA
SCHEMBL18323639 0.76 BRD4 (0.40) BRD4KDM4ELMNAKMT2A
SCHEMBL18323620 0.74 BRD4 (0.39) BRD4KDM4ELMNAKMT2ATSHR
SCHEMBL18323696 0.74 BRD4 (0.39) BRD4KDM4ELMNAKMT2A
SCHEMBL18323619 0.71 BRD4 (0.37) BRD4KDM4ELMNAKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 US disclosed